SCHEMBL9530399

SCHEMBL9530399

c1ccc2c(c1)CCNC2CCN1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 7/20 0.54
PRCP P42785 5/20 0.54
SLC22A1 O15245 1/20 0.54
GAA P10253 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3453173 0.85 OPRM1 (0.56) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL329925 0.84 OPRM1 (0.57) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL329828 0.84 OPRM1 (0.57) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL330238 0.84 OPRM1 (0.57) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL1009943 0.76 PRCP (0.64) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL5898800 0.76 PRCP (0.61) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL10741159 0.76 HTR2A (0.50)
SCHEMBL4340396 0.76 PRCP (0.61) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL14934071 0.76 PRCP (0.50) OPRM1PRCPSLC22A1GAASMN1; SMN2
SCHEMBL14934054 0.76 PRCP (0.50) OPRM1PRCPSLC22A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0330360-B1 1,2,3,4-Tetrahydroisoquinolines, processes for their preparation, and their use as kappa-receptor agonists SMITHKLINE BEECHAM FARMA (IT) 1993-12-01 EP disclosed
US-4954509-A Isoquinoline derivatives and their use as analgesics DR. LO. ZAMBELETTI S.P.A. (IT) 1990-09-04 US disclosed
EP-0330360-A1 1,2,3,4-Tetrahydroisoquinolines, processes for their preparation, and their use as kappa-receptor agonists SmithKline Beecham Farmaceutici S.p.A. (IT) 1989-08-30 EP disclosed